Your browser doesn't support javascript.
loading
Improved Detection of Drug-Induced Liver Injury by Integrating Predicted in vivo and in vitro Data.
Seal, Srijit; Williams, Dominic P; Hosseini-Gerami, Layla; Mahale, Manas; Carpenter, Anne E; Spjuth, Ola; Bender, Andreas.
Afiliação
  • Seal S; Yusuf Hamied Department of Chemistry, University of Cambridge, Lensfield Rd, CB2 1EW, Cambridge, United Kingdom.
  • Williams DP; Imaging Platform, Broad Institute of MIT and Harvard, US.
  • Hosseini-Gerami L; Safety Innovation, Clinical Pharmacology and Safety Sciences, AstraZeneca, Cambridge CB4 0FZ, United Kingdom.
  • Mahale M; Quantitative Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0FZ, United Kingdom.
  • Carpenter AE; Ignota Labs, County Hall, Westminster Bridge Rd, SE1 7PB, London, United Kingdom.
  • Spjuth O; Bombay College of Pharmacy Kalina Santacruz (E), Mumbai 400 098, India.
  • Bender A; Imaging Platform, Broad Institute of MIT and Harvard, US.
bioRxiv ; 2024 Jun 08.
Article em En | MEDLINE | ID: mdl-38895462
ABSTRACT
Drug-induced liver injury (DILI) has been significant challenge in drug discovery, often leading to clinical trial failures and necessitating drug withdrawals. The existing suite of in vitro proxy-DILI assays is generally effective at identifying compounds with hepatotoxicity. However, there is considerable interest in enhancing in silico prediction of DILI because it allows for the evaluation of large sets of compounds more quickly and cost-effectively, particularly in the early stages of projects. In this study, we aim to study ML models for DILI prediction that first predicts nine proxy-DILI labels and then uses them as features in addition to chemical structural features to predict DILI. The features include in vitro (e.g., mitochondrial toxicity, bile salt export pump inhibition) data, in vivo (e.g., preclinical rat hepatotoxicity studies) data, pharmacokinetic parameters of maximum concentration, structural fingerprints, and physicochemical parameters. We trained DILI-prediction models on 888 compounds from the DILIst dataset and tested on a held-out external test set of 223 compounds from DILIst dataset. The best model, DILIPredictor, attained an AUC-ROC of 0.79. This model enabled the detection of top 25 toxic compounds compared to models using only structural features (2.68 LR+ score). Using feature interpretation from DILIPredictor, we were able to identify the chemical substructures causing DILI as well as differentiate cases DILI is caused by compounds in animals but not in humans. For example, DILIPredictor correctly recognized 2-butoxyethanol as non-toxic in humans despite its hepatotoxicity in mice models. Overall, the DILIPredictor model improves the detection of compounds causing DILI with an improved differentiation between animal and human sensitivity as well as the potential for mechanism evaluation. DILIPredictor is publicly available at https//broad.io/DILIPredictor for use via web interface and with all code available for download and local implementation via https//pypi.org/project/dilipred/.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: BioRxiv Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: BioRxiv Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Reino Unido